CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in CASI Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −1 vs. Q3 2023
- Shares held
- 277.4K
- −67.2K (−19.5%) vs. Q3 2023
- Total value
- $1.99M
- +$1.11M (+125.7%) vs. Q3 2023
- New holders
- 3
- 3 more added
- Sold out
- 4
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC | 133,146 | $953.3K | 0.12% | −20,309−13.2% | Reduced |
| Wellington Shields & Co., LLC | 43,091 | $308.5K | 0.11% | −31,075−41.9% | Reduced |
| Renaissance Technologies LLC | 29,100 | $208.0K | 0.00% | +11,300+63.5% | Added |
| Geode Capital Management, LLC | 22,221 | $161.5K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 19,743 | $143.5K | 0.00% | −34−0.2% | Reduced |
| Citadel Advisors LLC | 12,916 | $93.9K | 0.00% | +12,916 | New |
| Jane Street Group, LLC | 12,538 | $89.8K | 0.00% | −9,586−43.3% | Reduced |
| Morgan Stanley | 2,906 | $20.8K | 0.00% | +1,353+87.1% | Added |
| UBS Group AG | 1,222 | $8.75K | 0.00% | +1,222 | New |
| BlackRock Inc. | 296 | $2.12K | 0.00% | −28−8.6% | Reduced |
| West Paces Advisors Inc. | 100 | $716 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 50 | $364 | 0.00% | +25+100.0% | Added |
| Northwestern Mutual Wealth Management Co | 13 | $93 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $79 | 0.00% | 00.0% | Unchanged |
| Kozak & Associates, Inc. | 10 | $54 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6 | $43 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3 | $21 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 53 | $0 | 0.00% | +53 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −32,365−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −328−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −327−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −18−100.0% | Sold out |